Home » Topics » BioWorld Science

BioWorld Science
RSS

Preclinical through phase III, new COVID-19 therapy trials ramp up

April 30, 2021

Mesoblast reports 60-day results on remestemcel-L in COVID-19 related ARDS

April 30, 2021

Phase II trial evaluates ImmunityBio Anktiva with ART to inhibit HIV reservoirs

April 30, 2021

Phase IIb/III study of masitinib in metastatic CRPC meets primary endpoint

April 30, 2021

Phase II trial of vonoprazan regimens for H. pylori infection meets endpoints

April 30, 2021

miR-206 is a prognostic marker of LGMDD2 disease progression

April 30, 2021

Neuromelanin MRI predicts treatment response in patients with first-episode schizophrenia

April 30, 2021

MiR-17-92 as a therapeutic target in lupus nephritis and other autoimmune diseases

April 30, 2021

PRT-1419 shows potent antitumor activity in preclinical models

April 30, 2021

Phase III NEPTUNO study of plitidepsin in COVID-19 receives authorization in Spain

April 30, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026